AlanDavidDandreaMD

Pediatric Hematology & Oncology • Boston, MA

Physician

Join to view full profile

Are you Dr. Dandrea?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
44 Binney St
Dana Farber Cancer Institute
Boston, MA 02115
Phone+1 617-632-2112

Fax+1 617-632-5757

Summary

Dr. Alan Dandrea, MD is a pediatric hematologist/oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania. He is affiliated with Dana-Farber Cancer Institute.

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1990
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1983 - 1986
Harvard Medical SchoolClass of 1983

Certifications & Licensure

MA State Medical License 1987 - 2025
PA State Medical License 1985 - 1986
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

19 citations
The Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair.
Richard O. Adeyemi, Nicholas A. Willis, Andrew E. H. Elia, Connor Clairmont, Shibo Li
Molecular Cell. 2021-11-04
1 citations
Isolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays.
Alfredo E. Rodriguez, Jessica Filiatrault, Patricia Flores-Guzmán, Hector Mayani, Kalindi Parmar
STAR Protocols. 2021-09-27
36 citations
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
Panagiotis A. Konstantinopoulos, Alexandre André B.A. da Costa, Doga Gulhan, Elizabeth K. Lee, Su Chun Cheng
Nature Communications. 2021-09-22

Press Mentions

Dana-Farber Clinical Investigators Leverage Rich Patient Samples to Pursue Novel Cancer TherapiesDecember 3rd, 2019
Clinical Trial Underscores Promise of Immunotherapy, in Combination with Second Drug, for Ovarian CancerJuly 13th, 2019
PARI (PARPBP) Suppresses Replication Stress-Induced Myeloid Differentiation in Leukemia CellsJuly 1st, 2019
Join now to see all